Lars Jøran Kjerpeseth
Medical officer
Contact
Send email {model.translations.sendEmailTo} Lars.Kjerpeseth@fhi.no
Department
Responsibilities
Noncommunicable diseases (NCDs)
Projects and publications
- Sergej Ostojic, Nowell H. Phelps, Rosie K. Singleton, Bin Zhou, Rachel Heap, Anu Mishra, James B. Bennett, Christopher J Paciorek, Victor P.F. Lhoste, Rodrigo Carillo-Larco, Gretchen A. Stevens, Andrea Rodriguez-Martinez, Honor Bixby, James Bentham, Mariachiara Danaei, Archie Rayner, Ana Barradas-Pires, Melanie J Cowan, Stefan Savin, Leanne M Riley, Carlos Aguilar-Salinas, Krishna Kumar Aryal, Lars Bo Andersen, Sigmund Alfred Anderssen, Inger Kristine Holtermann Ariansen, Elling Tufte Bere, Ingunn Holden Bergh, Ulf Ekelund, Espen Bjertness, Marius Bergsmark Bjertness, Eva Gerdts, Else Karin Grøholt, Teresa Risan Haugsgjerd, Aung Soe Htet, Jannicke Igland, Imre Janszky, Lars Jøran Kjerpeseth, Elin Kolle, Steinar Krokstad, Ahmed Ali Madar, Ellisiv B. Mathiesen, Jørgen Rajan Meisfjord, Haakon Eduard Meyer, Abhijit Sen, Elin Pettersen Sørgjerd, Bente Sparboe-Nilsen, Jostein Steene-Johannessen, Silje Steinsbekk, Gerhard Sulo, Grethe S. Tell, Liv Elin Torheim, Frøydis Nordgård Vik, Lars Wichstrøm, Tom Wilsgaard, (2024). Worldwide trends in the underweight and obesity from 1990 to 2022: a pooled analysis of 3,633 population-representative studies with 222 million school-aged children, adolescents, and adults. The Lancet s. 1027-1050. doi: 10.1016/S0140-6736(23)02750-2
- Adrienne Y. L. Chan, Le Gao, Miyuki Hsing-Chun Hsieh, Lars J. Kjerpeseth, Raquel Avelar, Tobias Banaschewski, Amy Hai Yan Chan, David Coghill, Jacqueline M. Cohen, Mika Gissler, Jeff Harrison, Patrick Ip, Øystein Karlstad, Wallis C. Y. Lau, Maarit K. Leinonen, Wing Cheong Leung, Tzu-Chi Liao, Johan Reutfors, Shih-Chieh Shao, Emily Simonoff, Kathryn Choon Beng Tan, Katja Taxis, Andrew Tomlin, Carolyn E. Cesta, Edward Chia-Cheng Lai, Helga Zoega, Kenneth K. C. Man, Ian C. K. Wong, (2024). Maternal diabetes and risk of attention-deficit/hyperactivity disorder in offspring in a multinational cohort of 3.6 million mother–child pairs. Nature Medicine s. 1416-1423. doi: 10.1038/s41591-024-02917-8
- Jacqueline Mallory Cohen, Silje Alvestad, Elizabeth A. Suarez, Andrea Schaffer, Randi M. Selmer, Alys Havard, Brian T. Bateman, Carolyn E. Cesta, Helga Zoega, Ingvild Odsbu, Krista F. Huybrechts, Lars J. Kjerpeseth, Loreen Straub, Maarit K. Leinonen, Marte-Helene Bjørk, Mette Nørgaard, Mika Gissler, Sinna P. Ulrichsen, Sonia Hernandez-Diaz, Torbjörn Tomson, Kari Furu, (2023). Comparative Risk of Major Congenital Malformations With Antiseizure Medication Combinations vs Valproate Monotherapy in Pregnancy. Neurology doi: 10.1212/WNL.0000000000207996
- Mariam Anjum, Inger Ariansen, Vidar Hjellvik, Randi Marie Selmer, Lars Jøran Kjerpeseth, Eva Skovlund, Marius Myrstad, Hanne Ellekjær, Ingrid E. Christophersen, Arnljot Tveit, Trygve Berge, (2023). Stroke and bleeding risk in atrial fibrillation with CHA2DS2-VASC risk score of one: the Norwegian AFNOR study. European Heart Journal s. 57-66. doi: 10.1093/eurheartj/ehad659
- Carolyn E. Cesta, Ran Rotem, Brian T. Bateman, Gabriel Chodick, Jacqueline Mallory Cohen, Kari Furu, Mika Gissler, Krista F. Huybrechts, Lars Jøran Kjerpeseth, Maarit K. Leinonen, Laura Pazzagli, Helga Zoega, Ellen W. Seely, Elisabetta Patorno, Sonia Hernández-Díaz, (2023). Safety of GLP-1 Receptor Agonists and Other Second-Line Antidiabetics in Early Pregnancy. JAMA Internal Medicine s. 144-152. doi: 10.1001/jamainternmed.2023.6663
- Lars Jøran Kjerpeseth, Vidar Hjellvik, Hanne Løvdal Gulseth, Øystein Karlstad, Paz Lopez-Doriga Ruiz, Knut-Arne Wensaas, Kari Furu, (2023). Prevalence and treatment of gestational diabetes in Norway 2010–2020. Diabetes Research and Clinical Practice s. 1-8. doi: 10.1016/j.diabres.2023.111025
- Lars Jøran Kjerpeseth, Carolyn E. Cesta, Kari Furu, Anders Engeland, Mika Gissler, Hanne Løvdal Gulseth, Øystein Karlstad, Maarit Leinonen, Laura Pazzagli, Helga Zoega, Jacqueline Mallory Cohen, (2023). Metformin Versus Insulin and Risk of Major Congenital Malformations in Pregnancies With Type 2 Diabetes: A Nordic Register-Based Cohort Study. Diabetes Care s. 1556-1564. doi: 10.2337/dc23-0256
- J. J. Komen, N. B. Hunt, A. Pottegård, P. Hjemdahl, B. Wettermark, M. Olesen, M. Bennie, T. Mueller, R. Carragher, Øystein Karlstad, Lars Jøran Kjerpeseth, O. H. Klungel, T. Forslund, (2023). Heterogeneity after harmonisation: A retrospective cohort study of bleeding and stroke risk after the introduction of direct oral anticoagulants in four Western European countries. Pharmacoepidemiology and Drug Safety s. 1223-1232. doi: 10.1002/pds.5650
- Emilie R. Hegelund, Lars Jøran Kjerpeseth, Laust H. Mortensen, Jannicke Igland, Trygve Berge, Mariam Anjum, Grethe S. Tell, Inger Kristine Holtermann Ariansen, (2022). Prevalence and Incidence Rates of Atrial Fibrillation in Denmark 2004–2018. Clinical Epidemiology s. 1193-1204. doi: 10.2147/CLEP.S374468
- Joris J. Komen, Anton Pottegård, Aukje K. Mantel-Teeuwisse, Tomas Forslund, Paul Hjemdahl, Björn Wettermark, Jesper Hallas, Morten Olesen, Marion Bennie, Tanja Mueller, Raymond Carragher, Øystein Karlstad, Lars Jøran Kjerpeseth, Olaf H. Klungel, (2022). Oral anticoagulants in patients with atrial fibrillation at low stroke risk: a multicentre observational study. European Heart Journal s. 3528-3538. doi: 10.1093/eurheartj/ehac111
- Jacqueline Mallory Cohen, Carolyn E. Cesta, Lars Jøran Kjerpeseth, Maarit K. Leinonen, Oskar Halfdanarson, Øystein Karlstad, Pär Karlsson, Morten Andersen, Kari Furu, Vidar Hjellvik, (2021). A common data model for harmonization in the Nordic Pregnancy Drug Safety Studies (NorPreSS). Norsk Epidemiologi s. 117-135. doi: 10.5324/nje.v29i1-2.4053
- Joris J. Komen, Anton Pottegård, Aukje K. Mantel-Teeuwisse, Tomas Forslund, Paul Hjemdahl, Björn Wettermark, Maja Hellfritzsch, Jesper Hallas, Morten Olesen, Marion Bennie, Tanja Mueller, Annemarie Voss, Tania Schink, Ulrike Haug, Bianca Kollhorst, Øystein Karlstad, Lars Jøran Kjerpeseth, Olaf H. Klungel, (2021). Persistence and adherence to non-vitamin K antagonist oral anticoagulant treatment in patients with atrial fibrillation across five Western European countries. Europace s. 1722-1730. doi: 10.1093/europace/euab091
- Katrine Bødkergaard, Randi Marie Selmer, Jesper Hallas, Lars Jøran Kjerpeseth, Eva Skovlund, Henrik Støvring, (2021). Using multiple random index dates with the reverse waiting time distribution improves precision of estimated prescription durations. Pharmacoepidemiology and Drug Safety s. 1727-1734. doi: 10.1002/pds.5340
- Katrine Bødkergaard, Randi Marie Selmer, Jesper Hallas, Lars Jøran Kjerpeseth, Anton Pottegård, Eva Skovlund, Henrik Støvring, (2020). Using the waiting time distribution with random index dates to estimate prescription durations in the presence of seasonal stockpiling. Pharmacoepidemiology and Drug Safety s. 1072-1078. doi: 10.1002/pds.5026
- Lars Jøran Kjerpeseth, Jannicke Igland, Randi Marie Selmer, Hanne Ellekjær, Arnljot Tveit, Trygve Berge, Silje Madeleine Kalstø, Ingrid E. Christophersen, Marius Myrstad, Eva Skovlund, Grace M. Egeland, Grethe Seppola Tell, Inger Ariansen, (2020). Prevalence and incidence rates of atrial fibrillation in Norway 2004-2014. Heart s. 201-207. doi: 10.1136/heartjnl-2020-316624
- Lars Jøran Kjerpeseth, Randi Marie Selmer, Inger Ariansen, Øystein Karlstad, Hanne Ellekjær, Eva Skovlund, (2019). Comparative effectiveness of warfarin, dabigatran, rivaroxaban and apixaban in nonvalvular atrial fibrillation: A nationwide pharmacoepidemiological study. PLOS ONE s. 1-18. doi: 10.1371/journal.pone.0221500
- Lars Jøran Kjerpeseth, Hanne Ellekjær, Randi Selmer, Inger Kristine Holtermann Ariansen, Kari Furu, Eva Skovlund, (2018). Risk factors for stroke and choice of oral anticoagulant in atrial fibrillation. European Journal of Clinical Pharmacology s. 1653-1662. doi: 10.1007/s00228-018-2540-3
- Lars Jøran Kjerpeseth, Hanne Ellekjær, Randi Selmer, Inger Kristine Ariansen, Kari Furu, Eva Skovlund, (2017). Trends in use of warfarin and direct oral anticoagulants in atrial fibrillation in Norway, 2010 to 2015. European Journal of Clinical Pharmacology s. 1417-1425. doi: 10.1007/s00228-017-2296-1
- Eva Bernhoff, Garth Daryl Tylden, Lars Jøran Kjerpeseth, Tore Jarl Gutteberg, Hans H. Hirsch, Christine H Rinaldo, (2010). Leflunomide Inhibition of BK Virus Replication in Renal Tubular Epithelial Cells. Journal of Virology s. 2150-2156. doi: 10.1128/JVI.01737-09
- Knut Eirik Dalene, Simon Lergenmuller, Vidar Hjellvik, Hein Stigum, Haakon Eduard Meyer, Wenche Nystad, Inger Kristin Larsen, Erik Reidar Sund, Steinar Krokstad, Laila Arnesdatter Hopstock, Ulf Ekelund, Lars Jøran Kjerpeseth, Inger Ariansen, (2024). Noncommunicable disease risk factor groups, socioeconomic position and longevity in Norway: a prospective cohort study of 576 299 men and women – the NCDNOR project.
- Simon Lergenmuller, Trude Eid Robsahm, Yngvar Nilssen, Knut Eirik Dalene, Wenche Nystad, Haakon Eduard Meyer, Hein Stigum, Vidar Hjellvik, Lars Jøran Kjerpeseth, Inger Ariansen, Inger Kristin Larsen, (2024). Patterns, prevalence, and risk of noncommunicable disease comorbidities and death in cancer patients: A comprehensive nationwide Norwegian registry study – the NCDNOR Project.
- Lars Jøran Kjerpeseth, Vidar Hjellvik, Inger Ariansen, Jørgen Gustav Bramness, Knut Eirik Dalene, Steinar Krokstad, Arnulf Langhammer, Inger Kristin Larsen, Simon Lergenmuller, Haakon Eduard Meyer, Øyvind Erik Næss, (2024). NCD multimorbidity in Norway 2010-2020 – a NCDNOR study.
- Lars Jøran Kjerpeseth, Vidar Hjellvik, Inger Ariansen, Jørgen Gustav Bramness, Knut Eirik Dalene, Steinar Krokstad, Inger Kristin Larsen, Haakon Eduard Meyer, Øyvind Erik Næss, Paz Lopez-Doriga Ruiz, Martin Steen Tesli, Wenche Nystad, (2024). Social disparities in multimorbidity of noncommunicable diseases in Norway 2010-2020 – an emerging challenge in a single-disease-focused healthcare system. Data from the NCDNOR project.
- Simon Lergenmuller, Trude Eid Robsahm, Yngvar Nilssen, Knut Eirik Dalene, Wenche Nystad, Haakon Eduard Meyer, Hein Stigum, Vidar Hjellvik, Lars Jøran Kjerpeseth, Inger Ariansen, Inger Kristin Larsen, (2024). Prevalence, Patterns, and Risk of Comorbidities and Death in Cancer Patients: A Nationwide Norwegian Registry Study – the NCDNOR Project.
- Knut Eirik Dalene, Simon Lergenmuller, Erik Reidar Sund, Steinar Krokstad, Laila Arnesdatter Hopstock, Wenche Nystad, Inger Kristin Larsen, Ulf Ekelund, Haakon Eduard Meyer, Hein Stigum, Vidar Hjellvik, Lars Jøran Kjerpeseth, Inger Ariansen, (2024). Latent risk factor profiles in the Norwegian adult population over time and their association with premature NCD mortality – the NCDNOR project..
- T. Berge, Øyvind Erik Næss, Torbjørn Wisløff, L. H. Mortensen, Eva Skovlund, Øystein Karlstad, Vidar Hjellvik, Lars Jøran Kjerpeseth, Grace M. Egeland, Jannicke Igland, Grethe S. Tell, Emilie R. Hegelund, Mariam Anjum, Ingrid E. Christophersen, M Myrstad, A. Tveit, Inger Ariansen, (2023). Registry tool for stroke prevention in atrial fibrillation in Norway – RegTool AFNOR.
- Martin Steen Tesli, Vidar Hjellvik, Anders Andreas Krister Jangmo, Marit Haram, Inger Ariansen, Steinar Krokstad, Ronald Kessler, Lars Jøran Kjerpeseth, Wenche Nystad, Jørgen Gustav Bramness, (2023). A comprehensive exploration of comorbidity patterns between mental disorders and non-communicable somatic diseases.
- Lars Jøran Kjerpeseth, Vidar Hjellvik, Inger Ariansen, Jørgen Gustav Bramness, Knut Eirik Dalene, Steinar Krokstad, Inger Kristin Larsen, Haakon Eduard Meyer, Øyvind Erik Næss, Paz Lopez-Doriga Ruiz, Wenche Nystad, (2023). NCD multimorbidity in Norway 2010-2020 – a NCDNOR study.
- Paz Lopez-Doriga Ruiz, Jacqueline Mallory Cohen, Lars Jøran Kjerpeseth, Kari Furu, Elisabeth Qvigstad, (2023). Paternal use of Metformin and Risk of Major Congenital Malformations.